OFFICIAL LEGAL TITLE
Recall Unsafe Drugs Act of 2022
FREQUENTLY ASKED QUESTIONS
What is the official ID of this bill?
The official print number for this legislation is 117_HR_6834.
Which chamber initiated this legislation?
This legislation was initiated in the House of Representatives.
When did the legislative process begin?
The process officially started on 2022-02-25.
What are the main provisions?
Key points include:
- Increased authority for officials to order immediate recall of dangerous drugs from the market.
- Pharmaceutical companies must report drugs that may pose a serious threat to health or life.
- Requirement for companies to have drug recall plans in place.
- Ability to quickly appeal a drug recall order, but the recall must proceed during the appeal.
What is the specific legal status?
The current status is Expired.
Where can I read the full text of this legislation?
The full official text is available at:
View full text
Who is the primary sponsor?
The primary sponsor is Rep. DeLauro, Rosa L. [D-CT-3].
What is the latest detailed status?
The latest detailed status is: Referred to the Subcommittee on Health.
Is this summary verified?
Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.